Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JinFuKang in Early-Stage NSCLC After Surgery
NCT02603003Phase 1Completed
- Sponsor
- Shanghai University of Traditional Chinese Medicine
- Start
- Jun 2015
- Primary completion
- Sep 2019
- Modality
- Small Molecules
01
Overview
Phase 1, randomised trial of jinfukang in non-small cell lung cancer (NSCLC), sponsored by Shanghai University of Traditional Chinese Medicine. Primary endpoint: Progression-Free Survival at 2 years. Started Jun 2015; status: completed.
02
Drugs
jinfukang
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02603003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02603003.